Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx)
Open accessThe DOI matches its Crossref record; 53 of the 56 references it cites were found in a registry or an index; 31 of the 52 sources its claims cite were checked for support.
Abstract
The obesity epidemic and its health consequences have not spared the population of kidney transplant (KTx) candidates and recipients. In addition, KTx recipients are susceptible to weight gain after transplantation. Overweight and obesity after KTx are strongly associated with adverse outcomes. Therefore, we designed a randomized controlled, mono-center study to specifically test the effectiveness of a primarily cognitive-behavioral approach supplemented by nutritional counseling for weight reduction following KTx as the intervention group (IG) in comparison to a brief self-guided intervention as control group (CG). The study was registered in the German Clinical Trials Register (DRKS-ID: DRKS00017226). Fifty-six KTx patients with a BMI from 27 to 40 kg/m2 were included in this study and randomized to the IG or CG. Main outcome was the number of participants achieving a 5% weight loss during the treatment phase. Additionally, participants were assessed 6 and 12 months after the end of the 6-month treatment phase. Participants significantly lost weight without group differences. 32.0% (n = 8) of the patients in the IG and 16.7% (n = 4) of the patients in the CG achieved a weight loss of 5% or more. Weight loss was largely maintained during follow-up. Retention and acceptance rate in the IG was high, with 25 (out of 28) patients completing all 12 sessions and one patient completing 11 sessions. Short-term, cognitive-behaviorally oriented weight loss treatment seems to be feasible and acceptable for patients after KTx who suffer from overweight or obesity. This clinical trial was ongoing at the onset of the COVID-19 pandemic which might have influenced study conduct and results. Clinical Trial Registration: https://clinicaltrials.gov/ DRKS-ID: DRKS00017226. Copyright © 2023 Barchfeld, Vagi, Lüdtke, Schieffer, Güler, Einecke, Jäger, de Zwaan and Nöhre.
Overview
CoChat Summary
## TL;DR
In this pilot randomized controlled trial of 56 adult kidney transplant recipients with overweight/obesity, a 6-month cognitive-behavioral plus dietary intervention did not significantly outperform a brief self-guided leaflet intervention for achieving ≥5% weight loss. Weight loss was modest in both groups, but retention was high and the intervention was described as feasible and acceptable.
## Key findings
- The primary outcome was not met: in the completer analysis, 32.0% (8/25) of the intervention group vs 16.7% (4/24) of the control group achieved ≥5% weight loss; in the ITT analysis, the corresponding proportions were 28.6% vs 14.3%. The between-group differences were not statistically significant (completer: χ² = 1.557, p = 0.212, φ = 0.178; ITT: χ² = 1.697, p = 0.193, φ = 0.071).
- Mean weight loss at end of treatment was modest: 2.9% (SD 5.4) in the intervention group and 0.6% (SD 4.2) in the control group in the completer sample; 2.6% (SD 5.2) vs 0.5% (SD 3.9) in the ITT sample. The differences were not statistically significant.
- BMI decreased over time across groups (F = 2.977, df = 3, p = 0.034), but there was no significant treatment-by-visit interaction at end of treatment or follow-up.
- eGFR increased over time (F = 3.070, df = 3, p = 0.030) without a treatment-by-visit interaction, and IWQOL-Lite total score improved over time across samples (F = 3.311, df = 3, p = 0.023). Quality of life and HADS scores were otherwise mostly within normal range and did not differ significantly by group.
## Methods
- Design: Mono-center, randomized controlled pilot trial; 56 kidney transplant recipients were randomized 28 per group to a 6-month intervention or brief self-guided control, with follow-up at 6 and 12 months after treatment.
- Sample/data: Adults ≥18 years, BMI 27–40 kg/m², and ≥3 months after kidney transplantation; recruitment occurred June 2019 to September 2020 at Hannover Medical School.
- Analysis: Primary analysis was a responder analysis comparing the proportion achieving ≥5% weight loss using chi-square tests, with completer and ITT analyses; secondary outcomes were analyzed with linear mixed models / MMRM for repeated measures.
## Limitations
- The paper states that the sample size was relatively small, which may limit power to detect small differences.
- The authors state they did not monitor laboratory parameters such as plasma lipids, blood glucose, or blood pressure, and they did not systematically investigate the impact of the COVID-19 pandemic on individuals.
- The authors state that participants were highly motivated and likely not representative of all kidney transplant recipients, limiting generalizability to other centers or clinicians.
- Evident from the text: the study was conducted during the COVID-19 pandemic, and assessments/interventions were often shifted to telehealth/phone and mailed self-reports, which may have affected measurement consistency and completeness.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
22 Valid · 0 Not valid · 10 Not checked · 73 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Even though overweight and obesity after KTx are strongly associated with adverse outcomes in the long run, there is still a lack of evidence from randomized controlled weight reduction trials.”
§ Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx) > Introduction Overweight and obesity have become major global health problems. In the German general population, about 20% of the adult population is obese (BMI ≥ 30 kg/m2) (1, 2). The obesity epidemic and its health consequences have not spared the population of kidney transplant candidates and recipients (3). Kidney transplantation (KTx) is the treatment of choice for patients with end-stage renal disease (4). Due to organ shortage, KTx candidates in Germany must wait on average 8 years before receiving a post-mortal organ donation. The percentage of patients receiving a living kidney donation was 23.8% in 2021 and decreased during the last years (5). Thus, many patients are on dialysis for several years before transplantation. During dialysis treatment, a higher BMI is associated with better survival (6–9). This phenomenon has been referred to as the obesity paradox. After KTx; however, overweight and obesity are associated with less favorable outcomes. Most research focuses on the association between obesity and post-transplant outcomes and comorbidities. Several meta-analyzes summarized the literature on the impact of obesity on patient outcomes after kidney transplantation (6, 10–13). They reported higher rates of complications early after transplantation, including delayed graft functioning and surgical complications as well as a higher rate of adverse long-term complications such as cardiovascular diseases. Regarding the association between obesity and graft loss as well as morbidity, the findings are controversial (6, 10–13). Undeniable is the association between obesity and higher rates of hypertension, dyslipidemia, and diabetes mellitus in kidney transplant recipients (14). Additionally, an association between overweight and the development of new-onset diabetes after transplantation (NODAT) and hypertension has been described (12). Overall, the BMI after KTx seems to be more strongly related to adverse long-term outcomes than the pre-transplant BMI (15). There is evidence that KTx recipients are susceptible to weight gain after transplantation (16, 17). In a large German sample of patients before and after kidney transplantation (n = 433), the frequencies of obesity (BMI > 30 kg/m2) were 14.8% (before KTx) and 19.9% (after KTx), respectively. There was a strong association between post-transplant BMI categories and type 2 diabetes mellitus as well as new-onset diabetes after transplantation (NODAT). Above that, an association between increasing BMI and decreasing graft functioning (eGFR) was found (18). These results are cause for concerns and underline the necessity of obesity management in KTx patients. Multiple factors have been associated with post-transplant weight gain including relaxation of dietary restrictions, increased appetite and well-being, immunosuppressive medication (i.e., steroids), insulin treatment due to NODAT (19), and inadequate physical activity. Even though overweight and obesity after KTx are strongly associated with adverse outcomes in the long run, there is still a lack of evidence from randomized controlled weight reduction trials. Overweight and obesity after transplantation are potentially modifiable risk factors for poor outcome and thus an appropriate target for therapeutic interventions. In a recent Cochrane review of Conley et al. (20) focusing on interventions for weight loss in patients with chronic kidney disease, only four studies included KTx patients. Orazio et al. (21) performed a mixed lifestyle intervention including dietary modifications and an increase of physical activity. Tomlinson et al. (22) evaluated the effects of an appetite suppressant compared to a dietary intervention. Tzvetanov et al. (23) investigated the effectiveness of a combined robotic KTx and sleeve gastrectomy versus robotic KTx and a conservative weight loss program. The authors came to the conclusion that lifestyle-based weight loss interventions may result in weight loss in KTx recipients. Due to the limited study situation, more specific recommendations could not be made. There have been different intervention studies aiming at preventing or minimizing weight gain after KTx. Henggeler et al. (24) designed a randomized controlled trial comparing an intensive nutritional intervention with the goal to prevent weight gain during the first year after kidney transplantation with standard nutritional care. The mean weight increase over 12 months was 4.6% without any differences between the intervention and control group. In a feasibility study of Gibson et al. (25) focusing on a televideo physical activity and nutrition program, 10 KTx patients were randomly assigned to an intervention or a control group. Even though treatment adherence was high, the authors reported somewhat more weight gain in the intervention group compared to the control group. Apart from that, there are two RCTs in KTx recipients currently ongoing focusing on the prevention of weight gain (26) and the improvement of abnormal glucose metabolism parameters with weight changes as a secondary outcome (27). Based on these results, it can be summarized that studies and study protocols published so far focus primarily on nutrition and exercise interventions to prevent or reduce weight gain or achieve weight loss in KTx patients. Studies concentrating on cognitive-behavioral health approaches as the primary mode of action have–to our knowledge–not been published so far. According to the German S3 guideline “Obesity–Prevention and Treatment” (28), an intervention for weight loss should include different aspects: diet, exercise, and cognitive-behavioral elements. Taking into account that KTx recipients, especially those who received dialysis treatment over several years, have a high level of comorbidity and are often physically impaired, it becomes obvious that a large proportion of the patients is not able to perform high level physical exercise as a weight reduction strategy (29). Therefore, an intervention with the aim to reduce weight specifically designed for KTx recipients should concentrate on the dietary and cognitive-behavioral aspects in addition to routine daily physical activity. Therefore, we designed a randomized controlled, mono-center study to specifically test the effectiveness of a primarily cognitive-behavioral approach supplemented by one session of nutritional and exercise counseling for weight reduction following KTx. A self-guided leaflet-based intervention focusing on habit formation (the Ten Top Tips, 10TT, 30) was chosen as a minimal intervention control group.
What the sources say
- Partly supportedcites [20] Conley, 2021, Interventions for weight loss in people with chronic kidney disease who are overweight or obese, Cochrane Database Syst Rev sourceExperimental — accuracy not yet measured
The Discussion says evidence for weight-loss interventions is limited and of very low to low quality, supporting a lack of strong trial evidence. But the Results report four included studies involving 368 transplant recipients, so the review does not support an absence of randomized weight-loss trials in this population. (LLM, conf=0.86)
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“There was a strong association between post-transplant BMI categories and type 2 diabetes mellitus as well as new-onset diabetes after transplantation (NODAT).”
§ Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx) > Introduction Overweight and obesity have become major global health problems. In the German general population, about 20% of the adult population is obese (BMI ≥ 30 kg/m2) (1, 2). The obesity epidemic and its health consequences have not spared the population of kidney transplant candidates and recipients (3). Kidney transplantation (KTx) is the treatment of choice for patients with end-stage renal disease (4). Due to organ shortage, KTx candidates in Germany must wait on average 8 years before receiving a post-mortal organ donation. The percentage of patients receiving a living kidney donation was 23.8% in 2021 and decreased during the last years (5). Thus, many patients are on dialysis for several years before transplantation. During dialysis treatment, a higher BMI is associated with better survival (6–9). This phenomenon has been referred to as the obesity paradox. After KTx; however, overweight and obesity are associated with less favorable outcomes. Most research focuses on the association between obesity and post-transplant outcomes and comorbidities. Several meta-analyzes summarized the literature on the impact of obesity on patient outcomes after kidney transplantation (6, 10–13). They reported higher rates of complications early after transplantation, including delayed graft functioning and surgical complications as well as a higher rate of adverse long-term complications such as cardiovascular diseases. Regarding the association between obesity and graft loss as well as morbidity, the findings are controversial (6, 10–13). Undeniable is the association between obesity and higher rates of hypertension, dyslipidemia, and diabetes mellitus in kidney transplant recipients (14). Additionally, an association between overweight and the development of new-onset diabetes after transplantation (NODAT) and hypertension has been described (12). Overall, the BMI after KTx seems to be more strongly related to adverse long-term outcomes than the pre-transplant BMI (15). There is evidence that KTx recipients are susceptible to weight gain after transplantation (16, 17). In a large German sample of patients before and after kidney transplantation (n = 433), the frequencies of obesity (BMI > 30 kg/m2) were 14.8% (before KTx) and 19.9% (after KTx), respectively. There was a strong association between post-transplant BMI categories and type 2 diabetes mellitus as well as new-onset diabetes after transplantation (NODAT). Above that, an association between increasing BMI and decreasing graft functioning (eGFR) was found (18). These results are cause for concerns and underline the necessity of obesity management in KTx patients. Multiple factors have been associated with post-transplant weight gain including relaxation of dietary restrictions, increased appetite and well-being, immunosuppressive medication (i.e., steroids), insulin treatment due to NODAT (19), and inadequate physical activity. Even though overweight and obesity after KTx are strongly associated with adverse outcomes in the long run, there is still a lack of evidence from randomized controlled weight reduction trials. Overweight and obesity after transplantation are potentially modifiable risk factors for poor outcome and thus an appropriate target for therapeutic interventions. In a recent Cochrane review of Conley et al. (20) focusing on interventions for weight loss in patients with chronic kidney disease, only four studies included KTx patients. Orazio et al. (21) performed a mixed lifestyle intervention including dietary modifications and an increase of physical activity. Tomlinson et al. (22) evaluated the effects of an appetite suppressant compared to a dietary intervention. Tzvetanov et al. (23) investigated the effectiveness of a combined robotic KTx and sleeve gastrectomy versus robotic KTx and a conservative weight loss program. The authors came to the conclusion that lifestyle-based weight loss interventions may result in weight loss in KTx recipients. Due to the limited study situation, more specific recommendations could not be made. There have been different intervention studies aiming at preventing or minimizing weight gain after KTx. Henggeler et al. (24) designed a randomized controlled trial comparing an intensive nutritional intervention with the goal to prevent weight gain during the first year after kidney transplantation with standard nutritional care. The mean weight increase over 12 months was 4.6% without any differences between the intervention and control group. In a feasibility study of Gibson et al. (25) focusing on a televideo physical activity and nutrition program, 10 KTx patients were randomly assigned to an intervention or a control group. Even though treatment adherence was high, the authors reported somewhat more weight gain in the intervention group compared to the control group. Apart from that, there are two RCTs in KTx recipients currently ongoing focusing on the prevention of weight gain (26) and the improvement of abnormal glucose metabolism parameters with weight changes as a secondary outcome (27). Based on these results, it can be summarized that studies and study protocols published so far focus primarily on nutrition and exercise interventions to prevent or reduce weight gain or achieve weight loss in KTx patients. Studies concentrating on cognitive-behavioral health approaches as the primary mode of action have–to our knowledge–not been published so far. According to the German S3 guideline “Obesity–Prevention and Treatment” (28), an intervention for weight loss should include different aspects: diet, exercise, and cognitive-behavioral elements. Taking into account that KTx recipients, especially those who received dialysis treatment over several years, have a high level of comorbidity and are often physically impaired, it becomes obvious that a large proportion of the patients is not able to perform high level physical exercise as a weight reduction strategy (29). Therefore, an intervention with the aim to reduce weight specifically designed for KTx recipients should concentrate on the dietary and cognitive-behavioral aspects in addition to routine daily physical activity. Therefore, we designed a randomized controlled, mono-center study to specifically test the effectiveness of a primarily cognitive-behavioral approach supplemented by one session of nutritional and exercise counseling for weight reduction following KTx. A self-guided leaflet-based intervention focusing on habit formation (the Ten Top Tips, 10TT, 30) was chosen as a minimal intervention control group.
What the sources say
- Supportedcites [18] Nöhre, 2020, Obesity after kidney transplantation-results of a KTx360° substudy, Front Psych source
The Discussion explicitly reports a strong association between post-transplant BMI categories and both type 2 diabetes mellitus and NODAT. The Results section also reports significantly higher rates of both conditions across increasing BMI categories. (LLM, conf=0.95)
boostedstates an associationn = 433- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a large German sample of patients before and after kidney transplantation (n = 433), the frequencies of obesity (BMI > 30 kg/m2) were 14.8% (before KTx) and 19.9% (after KTx), respectively.”
§ Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx) > Introduction Overweight and obesity have become major global health problems. In the German general population, about 20% of the adult population is obese (BMI ≥ 30 kg/m2) (1, 2). The obesity epidemic and its health consequences have not spared the population of kidney transplant candidates and recipients (3). Kidney transplantation (KTx) is the treatment of choice for patients with end-stage renal disease (4). Due to organ shortage, KTx candidates in Germany must wait on average 8 years before receiving a post-mortal organ donation. The percentage of patients receiving a living kidney donation was 23.8% in 2021 and decreased during the last years (5). Thus, many patients are on dialysis for several years before transplantation. During dialysis treatment, a higher BMI is associated with better survival (6–9). This phenomenon has been referred to as the obesity paradox. After KTx; however, overweight and obesity are associated with less favorable outcomes. Most research focuses on the association between obesity and post-transplant outcomes and comorbidities. Several meta-analyzes summarized the literature on the impact of obesity on patient outcomes after kidney transplantation (6, 10–13). They reported higher rates of complications early after transplantation, including delayed graft functioning and surgical complications as well as a higher rate of adverse long-term complications such as cardiovascular diseases. Regarding the association between obesity and graft loss as well as morbidity, the findings are controversial (6, 10–13). Undeniable is the association between obesity and higher rates of hypertension, dyslipidemia, and diabetes mellitus in kidney transplant recipients (14). Additionally, an association between overweight and the development of new-onset diabetes after transplantation (NODAT) and hypertension has been described (12). Overall, the BMI after KTx seems to be more strongly related to adverse long-term outcomes than the pre-transplant BMI (15). There is evidence that KTx recipients are susceptible to weight gain after transplantation (16, 17). In a large German sample of patients before and after kidney transplantation (n = 433), the frequencies of obesity (BMI > 30 kg/m2) were 14.8% (before KTx) and 19.9% (after KTx), respectively. There was a strong association between post-transplant BMI categories and type 2 diabetes mellitus as well as new-onset diabetes after transplantation (NODAT). Above that, an association between increasing BMI and decreasing graft functioning (eGFR) was found (18). These results are cause for concerns and underline the necessity of obesity management in KTx patients. Multiple factors have been associated with post-transplant weight gain including relaxation of dietary restrictions, increased appetite and well-being, immunosuppressive medication (i.e., steroids), insulin treatment due to NODAT (19), and inadequate physical activity. Even though overweight and obesity after KTx are strongly associated with adverse outcomes in the long run, there is still a lack of evidence from randomized controlled weight reduction trials. Overweight and obesity after transplantation are potentially modifiable risk factors for poor outcome and thus an appropriate target for therapeutic interventions. In a recent Cochrane review of Conley et al. (20) focusing on interventions for weight loss in patients with chronic kidney disease, only four studies included KTx patients. Orazio et al. (21) performed a mixed lifestyle intervention including dietary modifications and an increase of physical activity. Tomlinson et al. (22) evaluated the effects of an appetite suppressant compared to a dietary intervention. Tzvetanov et al. (23) investigated the effectiveness of a combined robotic KTx and sleeve gastrectomy versus robotic KTx and a conservative weight loss program. The authors came to the conclusion that lifestyle-based weight loss interventions may result in weight loss in KTx recipients. Due to the limited study situation, more specific recommendations could not be made. There have been different intervention studies aiming at preventing or minimizing weight gain after KTx. Henggeler et al. (24) designed a randomized controlled trial comparing an intensive nutritional intervention with the goal to prevent weight gain during the first year after kidney transplantation with standard nutritional care. The mean weight increase over 12 months was 4.6% without any differences between the intervention and control group. In a feasibility study of Gibson et al. (25) focusing on a televideo physical activity and nutrition program, 10 KTx patients were randomly assigned to an intervention or a control group. Even though treatment adherence was high, the authors reported somewhat more weight gain in the intervention group compared to the control group. Apart from that, there are two RCTs in KTx recipients currently ongoing focusing on the prevention of weight gain (26) and the improvement of abnormal glucose metabolism parameters with weight changes as a secondary outcome (27). Based on these results, it can be summarized that studies and study protocols published so far focus primarily on nutrition and exercise interventions to prevent or reduce weight gain or achieve weight loss in KTx patients. Studies concentrating on cognitive-behavioral health approaches as the primary mode of action have–to our knowledge–not been published so far. According to the German S3 guideline “Obesity–Prevention and Treatment” (28), an intervention for weight loss should include different aspects: diet, exercise, and cognitive-behavioral elements. Taking into account that KTx recipients, especially those who received dialysis treatment over several years, have a high level of comorbidity and are often physically impaired, it becomes obvious that a large proportion of the patients is not able to perform high level physical exercise as a weight reduction strategy (29). Therefore, an intervention with the aim to reduce weight specifically designed for KTx recipients should concentrate on the dietary and cognitive-behavioral aspects in addition to routine daily physical activity. Therefore, we designed a randomized controlled, mono-center study to specifically test the effectiveness of a primarily cognitive-behavioral approach supplemented by one session of nutritional and exercise counseling for weight reduction following KTx. A self-guided leaflet-based intervention focusing on habit formation (the Ten Top Tips, 10TT, 30) was chosen as a minimal intervention control group.
What the sources say
- Supportedcites [18] Nöhre, 2020, Obesity after kidney transplantation-results of a KTx360° substudy, Front Psych source
The Discussion reports obesity frequencies of 14.8% before and 19.9% after kidney transplantation in a German sample of 433 patients, using the stated BMI threshold. The Results section also confirms the percentages. (LLM, conf=0.95)
plainn = 433- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Undeniable is the association between obesity and higher rates of hypertension, dyslipidemia, and diabetes mellitus in kidney transplant recipients (14).”
§ Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx) > Introduction Overweight and obesity have become major global health problems. In the German general population, about 20% of the adult population is obese (BMI ≥ 30 kg/m2) (1, 2). The obesity epidemic and its health consequences have not spared the population of kidney transplant candidates and recipients (3). Kidney transplantation (KTx) is the treatment of choice for patients with end-stage renal disease (4). Due to organ shortage, KTx candidates in Germany must wait on average 8 years before receiving a post-mortal organ donation. The percentage of patients receiving a living kidney donation was 23.8% in 2021 and decreased during the last years (5). Thus, many patients are on dialysis for several years before transplantation. During dialysis treatment, a higher BMI is associated with better survival (6–9). This phenomenon has been referred to as the obesity paradox. After KTx; however, overweight and obesity are associated with less favorable outcomes. Most research focuses on the association between obesity and post-transplant outcomes and comorbidities. Several meta-analyzes summarized the literature on the impact of obesity on patient outcomes after kidney transplantation (6, 10–13). They reported higher rates of complications early after transplantation, including delayed graft functioning and surgical complications as well as a higher rate of adverse long-term complications such as cardiovascular diseases. Regarding the association between obesity and graft loss as well as morbidity, the findings are controversial (6, 10–13). Undeniable is the association between obesity and higher rates of hypertension, dyslipidemia, and diabetes mellitus in kidney transplant recipients (14). Additionally, an association between overweight and the development of new-onset diabetes after transplantation (NODAT) and hypertension has been described (12). Overall, the BMI after KTx seems to be more strongly related to adverse long-term outcomes than the pre-transplant BMI (15). There is evidence that KTx recipients are susceptible to weight gain after transplantation (16, 17). In a large German sample of patients before and after kidney transplantation (n = 433), the frequencies of obesity (BMI > 30 kg/m2) were 14.8% (before KTx) and 19.9% (after KTx), respectively. There was a strong association between post-transplant BMI categories and type 2 diabetes mellitus as well as new-onset diabetes after transplantation (NODAT). Above that, an association between increasing BMI and decreasing graft functioning (eGFR) was found (18). These results are cause for concerns and underline the necessity of obesity management in KTx patients. Multiple factors have been associated with post-transplant weight gain including relaxation of dietary restrictions, increased appetite and well-being, immunosuppressive medication (i.e., steroids), insulin treatment due to NODAT (19), and inadequate physical activity. Even though overweight and obesity after KTx are strongly associated with adverse outcomes in the long run, there is still a lack of evidence from randomized controlled weight reduction trials. Overweight and obesity after transplantation are potentially modifiable risk factors for poor outcome and thus an appropriate target for therapeutic interventions. In a recent Cochrane review of Conley et al. (20) focusing on interventions for weight loss in patients with chronic kidney disease, only four studies included KTx patients. Orazio et al. (21) performed a mixed lifestyle intervention including dietary modifications and an increase of physical activity. Tomlinson et al. (22) evaluated the effects of an appetite suppressant compared to a dietary intervention. Tzvetanov et al. (23) investigated the effectiveness of a combined robotic KTx and sleeve gastrectomy versus robotic KTx and a conservative weight loss program. The authors came to the conclusion that lifestyle-based weight loss interventions may result in weight loss in KTx recipients. Due to the limited study situation, more specific recommendations could not be made. There have been different intervention studies aiming at preventing or minimizing weight gain after KTx. Henggeler et al. (24) designed a randomized controlled trial comparing an intensive nutritional intervention with the goal to prevent weight gain during the first year after kidney transplantation with standard nutritional care. The mean weight increase over 12 months was 4.6% without any differences between the intervention and control group. In a feasibility study of Gibson et al. (25) focusing on a televideo physical activity and nutrition program, 10 KTx patients were randomly assigned to an intervention or a control group. Even though treatment adherence was high, the authors reported somewhat more weight gain in the intervention group compared to the control group. Apart from that, there are two RCTs in KTx recipients currently ongoing focusing on the prevention of weight gain (26) and the improvement of abnormal glucose metabolism parameters with weight changes as a secondary outcome (27). Based on these results, it can be summarized that studies and study protocols published so far focus primarily on nutrition and exercise interventions to prevent or reduce weight gain or achieve weight loss in KTx patients. Studies concentrating on cognitive-behavioral health approaches as the primary mode of action have–to our knowledge–not been published so far. According to the German S3 guideline “Obesity–Prevention and Treatment” (28), an intervention for weight loss should include different aspects: diet, exercise, and cognitive-behavioral elements. Taking into account that KTx recipients, especially those who received dialysis treatment over several years, have a high level of comorbidity and are often physically impaired, it becomes obvious that a large proportion of the patients is not able to perform high level physical exercise as a weight reduction strategy (29). Therefore, an intervention with the aim to reduce weight specifically designed for KTx recipients should concentrate on the dietary and cognitive-behavioral aspects in addition to routine daily physical activity. Therefore, we designed a randomized controlled, mono-center study to specifically test the effectiveness of a primarily cognitive-behavioral approach supplemented by one session of nutritional and exercise counseling for weight reduction following KTx. A self-guided leaflet-based intervention focusing on habit formation (the Ten Top Tips, 10TT, 30) was chosen as a minimal intervention control group.
What the sources say
- Supportedcites [14] Chan, 2014, Obesity in kidney transplantation, J Ren Nutr source
The Introduction states that obesity leads to a higher prevalence of cardiovascular risk factors in kidney transplant recipients, explicitly including hypertension, dyslipidaemia, and diabetes mellitus. (LLM, conf=0.94)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a recent Cochrane review of Conley et al. (20) focusing on interventions for weight loss in patients with chronic kidney disease, only four studies included KTx patients.”
§ Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx) > Introduction Overweight and obesity have become major global health problems. In the German general population, about 20% of the adult population is obese (BMI ≥ 30 kg/m2) (1, 2). The obesity epidemic and its health consequences have not spared the population of kidney transplant candidates and recipients (3). Kidney transplantation (KTx) is the treatment of choice for patients with end-stage renal disease (4). Due to organ shortage, KTx candidates in Germany must wait on average 8 years before receiving a post-mortal organ donation. The percentage of patients receiving a living kidney donation was 23.8% in 2021 and decreased during the last years (5). Thus, many patients are on dialysis for several years before transplantation. During dialysis treatment, a higher BMI is associated with better survival (6–9). This phenomenon has been referred to as the obesity paradox. After KTx; however, overweight and obesity are associated with less favorable outcomes. Most research focuses on the association between obesity and post-transplant outcomes and comorbidities. Several meta-analyzes summarized the literature on the impact of obesity on patient outcomes after kidney transplantation (6, 10–13). They reported higher rates of complications early after transplantation, including delayed graft functioning and surgical complications as well as a higher rate of adverse long-term complications such as cardiovascular diseases. Regarding the association between obesity and graft loss as well as morbidity, the findings are controversial (6, 10–13). Undeniable is the association between obesity and higher rates of hypertension, dyslipidemia, and diabetes mellitus in kidney transplant recipients (14). Additionally, an association between overweight and the development of new-onset diabetes after transplantation (NODAT) and hypertension has been described (12). Overall, the BMI after KTx seems to be more strongly related to adverse long-term outcomes than the pre-transplant BMI (15). There is evidence that KTx recipients are susceptible to weight gain after transplantation (16, 17). In a large German sample of patients before and after kidney transplantation (n = 433), the frequencies of obesity (BMI > 30 kg/m2) were 14.8% (before KTx) and 19.9% (after KTx), respectively. There was a strong association between post-transplant BMI categories and type 2 diabetes mellitus as well as new-onset diabetes after transplantation (NODAT). Above that, an association between increasing BMI and decreasing graft functioning (eGFR) was found (18). These results are cause for concerns and underline the necessity of obesity management in KTx patients. Multiple factors have been associated with post-transplant weight gain including relaxation of dietary restrictions, increased appetite and well-being, immunosuppressive medication (i.e., steroids), insulin treatment due to NODAT (19), and inadequate physical activity. Even though overweight and obesity after KTx are strongly associated with adverse outcomes in the long run, there is still a lack of evidence from randomized controlled weight reduction trials. Overweight and obesity after transplantation are potentially modifiable risk factors for poor outcome and thus an appropriate target for therapeutic interventions. In a recent Cochrane review of Conley et al. (20) focusing on interventions for weight loss in patients with chronic kidney disease, only four studies included KTx patients. Orazio et al. (21) performed a mixed lifestyle intervention including dietary modifications and an increase of physical activity. Tomlinson et al. (22) evaluated the effects of an appetite suppressant compared to a dietary intervention. Tzvetanov et al. (23) investigated the effectiveness of a combined robotic KTx and sleeve gastrectomy versus robotic KTx and a conservative weight loss program. The authors came to the conclusion that lifestyle-based weight loss interventions may result in weight loss in KTx recipients. Due to the limited study situation, more specific recommendations could not be made. There have been different intervention studies aiming at preventing or minimizing weight gain after KTx. Henggeler et al. (24) designed a randomized controlled trial comparing an intensive nutritional intervention with the goal to prevent weight gain during the first year after kidney transplantation with standard nutritional care. The mean weight increase over 12 months was 4.6% without any differences between the intervention and control group. In a feasibility study of Gibson et al. (25) focusing on a televideo physical activity and nutrition program, 10 KTx patients were randomly assigned to an intervention or a control group. Even though treatment adherence was high, the authors reported somewhat more weight gain in the intervention group compared to the control group. Apart from that, there are two RCTs in KTx recipients currently ongoing focusing on the prevention of weight gain (26) and the improvement of abnormal glucose metabolism parameters with weight changes as a secondary outcome (27). Based on these results, it can be summarized that studies and study protocols published so far focus primarily on nutrition and exercise interventions to prevent or reduce weight gain or achieve weight loss in KTx patients. Studies concentrating on cognitive-behavioral health approaches as the primary mode of action have–to our knowledge–not been published so far. According to the German S3 guideline “Obesity–Prevention and Treatment” (28), an intervention for weight loss should include different aspects: diet, exercise, and cognitive-behavioral elements. Taking into account that KTx recipients, especially those who received dialysis treatment over several years, have a high level of comorbidity and are often physically impaired, it becomes obvious that a large proportion of the patients is not able to perform high level physical exercise as a weight reduction strategy (29). Therefore, an intervention with the aim to reduce weight specifically designed for KTx recipients should concentrate on the dietary and cognitive-behavioral aspects in addition to routine daily physical activity. Therefore, we designed a randomized controlled, mono-center study to specifically test the effectiveness of a primarily cognitive-behavioral approach supplemented by one session of nutritional and exercise counseling for weight reduction following KTx. A self-guided leaflet-based intervention focusing on habit formation (the Ten Top Tips, 10TT, 30) was chosen as a minimal intervention control group.
What the sources say
- Supportedcites [20] Conley, 2021, Interventions for weight loss in people with chronic kidney disease who are overweight or obese, Cochrane Database Syst Rev source
The Results (Participants) state that four of the 17 included studies were conducted with kidney transplant recipients, matching the claim. The review’s scope is weight-loss interventions for overweight or obese adults with chronic kidney disease. (LLM, conf=0.95)
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
41 more claims · 8 with their cited sources checked
Create a free account to see all 105 claims and every source verdict.
- It may state two separate claims as one. 33
- Probably not a substantial claim. 38
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx) > Results > Participants
“Overall, 91.1% (n = 51) of the participants were assessed at 12-month follow-up; assessment rate did not differ by group (IG 92.9%, CG 89.3%).”
§ Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx) > Results > Weight related primary and longer-term outcomes
“Of the participants who completed the 12-month follow-up (n = 48), 45.8% lost further weight following treatment.”
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · cited 7×
“Secondary analyzes included the analyzes of further outcome variables assessing quality of life (IWQOL-Lite total score, SF-12 composite scale scores), levels of anxiety and depression (HADS), and eGFR as a measure of kidney functioning.”
MethodInfluentialDepression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Scientists rise up against statistical significance
Amrhein, V., Greenland, S., & McShane, B. (2019) · Nature · doi:10.1038/d41586-019-00857-9 · Cited by 2,983 · cited 1×
“To prevent non-significant results from being falsely diminished in their relevance, several authors recommend concentrating on and reporting effect sizes, since they do not depend on factors such as sample size (42, 43).”
BackgroundReverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
Kalantar-Zadeh, K., Block, G., Humphreys, M. H., & Kopple, J. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00803.x · Cited by 1,247
Kalbe, E., Kessler, J., Calabrese, P., Smith, R., Passmore, A. P., Brand, M., & Bullock, R. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1042 · Cited by 766
Development of a brief measure to assess quality of life in obesity
Kolotkin, R. L., Crosby, R. D., Kosloski, K. D., & Williams, G. R. (2001) · Obesity Research · doi:10.1038/oby.2001.13 · Cited by 641
Wyld, M., Morton, R. L., Hayen, A., Howard, K., & Webster, A. C. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001307 · Cited by 515 · cited 1×
“Kidney transplantation (KTx) is the treatment of choice for patients with end-stage renal disease (4).”
BackgroundKalantar-Zadeh, K., Streja, E., Kovesdy, C. P., Oreopoulos, A., Noori, N., Jing, J., Nissenson, A. R., Krishnan, M., Kopple, J. D., Mehrotra, R., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0336 · Cited by 340
Healthy habits: efficacy of simple advice on weight control based on a habit-formation model
Lally, P., Chipperfield, A., & Wardle, J. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803771 · Cited by 250 · cited 1×
“The participants in the CG received a brief, self-guided intervention consisting of a leaflet containing healthy nutrition and activity recommendations and simple advice on habit formation (the Ten Top Tips, 10TT) (30).”
Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis
Lafranca, J. A., IJermans, J. N., Betjes, M. G., & Dor, F. J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0340-5 · Cited by 222 · cited 1×
“Additionally, an association between overweight and the development of new-onset diabetes after transplantation (NODAT) and hypertension has been described (12).”
Background
Research works printed but not linked: 2
- Herrmann-Lingen, 1995, HADS-D: Hospital Anxiety and Depression Scale–German Version
- Hilbert, 2010, Essanfälle und Adipositas: Ein Manual zur Kognitiv-behavioralen Therapie der Binge-Eating-Störung (Therapeutische Praxis)
Cited by
Self-Management Interventions for Kidney Transplant Recipients: A Systematic Review
Lee, H., & Kang, C. M. (2025) · Healthcare · doi:10.3390/healthcare13151918 · Cited by 8
“…p = 0.009) [44], diastolic blood pressure ( p = 0.00006) [44], HR ( p = 0.002) [46], WC ( p < 0.001) [46,48], and BMI ( p = 0.01) [46], ( p < 0.05) [33], weight ( p < 0.05) [33], ( p = 0.02) [47], HbA1c ( p < 0.05) [48], proteinuria ( p = 0.016) [48] Blood pressure [46,47], weight [46], BMI…”
InfluentialObesity and Its Clinical Implications in End-Stage Kidney Disease
Petrulienė, K., Žilinskienė, A., Vaičiūnienė, R., Vaičiūnas, K., Bumblytė, I. A., & Dalinkevičienė, E. (2026) · Medicina · doi:10.3390/medicina62010211 · Cited by 3
“Possible reason—COVID-19 pandemic interrupting the study with an influence of health behaviors [145].”
Mesarič, K. K., Kodrič, J., Bogataj, Š., Pernat, A. M., Kuzmanovski, A., Zakrajšek, B. L., & Pajek, J. (2025) · Journal of Behavioral Medicine · doi:10.1007/s10865-025-00583-w · Cited by 4
“A recent pilot study evaluating cognitive behavioral and dietary interven - tion for weight loss in kidney transplant recipients reported an average BMI reduction of 0.9 in the intervention group compared to 0.2 in the control group over a 12-session, six-month program (Barchfeld et al., 2023 ).”
InfluentialSelf Esteem in Diabetic Patients
Banariu, G. M., George, N., Rus, M., & Tica, V. (2024) · Springer eBooks · doi:10.1007/978-3-031-32046-0_36-1
Self-Esteem in Diabetic Patients
Banariu, G. M., George, N., Rus, M., & Tica, V. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_36
Metadata
- Authors
- Barchfeld, D. C., Vagi, R.-K., Lüdtke, K., Schieffer, E., Güler, F., Einecke, G., Jäger, B., de Zwaan, M., & Nöhre, M.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Philipps University of Marburg (DE)
- Corresponding author
- Nöhre, Mariel
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2023-04-11
- Volume
- 14
- Pages
- 1071705-1071705
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC10126341
- OpenAlex
- W4364374861
- Cited by
- 10
- References
- 56
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 1
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Niedersächsisches Ministerium für Wissenschaft und Kultur
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- kidney transplant recipients, obesity, overweight, weight loss interventions, cognitive behavioral therapy, nutrition counseling, dietary intervention, post-transplant weight gain, weight maintenance, feasibility and acceptability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx). https://app.cochat.ai/papers/10.3389/fpsyt.2023.1071705
- The paper
- Barchfeld, D. C., Vagi, R.-K., Lüdtke, K., Schieffer, E., Güler, F., Einecke, G., Jäger, B., de Zwaan, M., & Nöhre, M. (2023). Cognitive-behavioral and dietary weight loss intervention in adult kidney transplant recipients with overweight and obesity: Results of a pilot RCT study (Adi-KTx). Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1071705
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.